PEOPLE - American Scientific makes appointment:
This article was originally published in Clinica
Michael Cutrer, the founder, president and CEO of radiation therapy products firm American Scientific, has transitioned to the positions of executive vice-president and chief technology officer. The search for his successor is underway. Mr Cutrer made the change in order to focus on developing the Chatsworth, California firm's breast brachytherapy programme and other projects. American Scientific specialises in intensity modulated radiation therapy and image-guided radiation therapy, besides brachytherapy.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.